Healthcare Economist October 26, 2023
If you guessed manufacturers, you would be incorrect. At least that is according to a new study by Mattingly et al. (2023) in JAMA Health Forum. Using a sample of the 45 generic drugs with >$100m in Part D and used by >1m beneficiaries, the authors found that:
…Medicare Part D spent $11.8 billion for 690 million claims (mean, $22.50 per claim; 95% CI,...